SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-021096
Filing Date
2022-08-04
Accepted
2022-08-04 16:27:02
Documents
90
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akba-20220630.htm   iXBRL 10-Q 2212026
2 EX-10.5 exhibit105-retentionagreem.htm EX-10.5 12728
3 EX-10.6 exhibit106-formofofficerre.htm EX-10.6 32068
4 EX-10.7 exhibit107-formofofficerno.htm EX-10.7 43493
5 EX-10.8 exhibit108-terminationands.htm EX-10.8 130316
6 EX-10.9 exhibit109-secondamendment.htm EX-10.9 53293
7 EX-31.1 exhibit311-q22022.htm EX-31.1 11366
8 EX-31.2 exhibit312-q22022.htm EX-31.2 11406
9 EX-32.1 exhibit321-q22022.htm EX-32.1 9276
  Complete submission text file 0001628280-22-021096.txt   9792930

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akba-20220630.xsd EX-101.SCH 85742
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akba-20220630_cal.xml EX-101.CAL 96620
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akba-20220630_def.xml EX-101.DEF 371438
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akba-20220630_lab.xml EX-101.LAB 784939
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akba-20220630_pre.xml EX-101.PRE 548766
84 EXTRACTED XBRL INSTANCE DOCUMENT akba-20220630_htm.xml XML 1398112
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 221137047
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences